HD, a Thailand-based healthcare and surgery marketplace, has on Thursday announced the close of a Series A-1 strategic extension round with participation from the United States-based healthcare firm Merck Sharp & Dohme (MSD), bringing HD’s total Series A funding to $7.8 million.

HD said in a statement that with additional support from from MSD, HD is poised to expand its impact even further, making affordable, accessible healthcare a reality across Southeast Asia.

By 2025, the company aims to support over 5,000 healthcare providers and reach 600,000 patients through its HDmall and Jib AI which empower healthcare providers to focus more on patient care.

According to the statement, the funding marks the first investment by MSD IDEA Studio Asia Pacific, an initiative by the MSD Global Health Innovation Fund (MGHIF) and MSD Asia Pacific regional team to support and collaborate with early-stage companies delivering transformative healthcare solutions.

With this investment, MGHIF joins a roster of prominent investors, including SBI Ven Capital, M Venture Partners, FEBE Ventures, Partech Partners, Ratio Ventures, Orvel Ventures, and TA Ventures, who have collectively supported HD’s Series A funding round.

This participation demonstrates MGHIF’s commitment to advancing innovative healthcare in the Asia Pacific region and will enable HD to further expand its flagship HDmall healthcare marketplace and Jib AI technology.

It is noted that in the nine months since HD’s Series A round led by SBI Ven Capital, the company has doubled in growth and successfully developed and deployed its Jib AI technology.

Currently, over 60 percent of HD’s chat commerce is managed by autonomous AI agents, delivering high-quality, instant 24/7 responses to customers.

Most importantly, this technology enables healthcare professionals – nurses, physicians, and surgeons alike – to focus more on providing exceptional patient care, with Jib AI handling the majority of initial triaging and care navigation.

Over the next 12 months, Jib AI’s agent capabilities will further expand to include order and refund processing, assisted checkouts, scheduling, electronic health record querying and review, medical information retrieval through the Jib AI Health Assistant, and AI-enabled asynchronous virtual care with expert physicians.

“This investment from MGHIF, their first in Southeast Asia, underscores the importance of our mission,

“With MSD IDEA Studio Asia Pacific’s strategic support, HD’s extensive and rapidly growing network of over 2,500 healthcare providers, and our proprietary Jib AI technology, we’re excited to accelerate our journey toward making affordable, high-quality healthcare accessible to millions,” said Sheji Ho, Chief Executive Officer and Co-Founder of HD.

According to the statement, Jib AI’s success in enhancing healthcare navigation for patients while providing operating leverage has attracted strong interest from healthcare providers on the HDmall marketplace, who are eager to integrate Jib AI into their direct channels and day-to-day operations.

As healthcare providers’ needs continue to evolve, HD remains committed to empowering them with innovative solutions that enable better, more affordable, and patient-centered care in the digital era.

“Today’s announcement represents a significant milestone as we make our inaugural investment through MSD’s IDEA Studio Asia Pacific fund,” said Saumick Pal, Head of Digital, Data Analytics & Innovation, MSD Asia Pacific.

“We look forward to collaborating closely with the talented team at HD, a pioneering healthcare and surgery marketplace with a well-established presence in Thailand,

“Together, we are committed to supporting the vision of improving access to affordable healthcare services, enhancing patient outcomes, and driving transformative change in healthcare across the Asia Pacific region,” he added.

The Series A-1 extension also marks a significant milestone for HD, which has already facilitated healthcare access for over 400,000 patients through its platform, said the statement.

HD is a healthcare and surgery marketplace in emerging Southeast Asia, powering over 2,500 healthcare providers, including some of the region’s largest hospitals.

The firm connects patients to hospitals, clinics, operating rooms, and surgeons while offering healthcare financing solutions to increase access to affordable care and surgeries.

Its suite of products includes HDmall, an outpatient healthcare marketplace operating in Thailand and Indonesia, with plans to enter Vietnam, and Jib AI, an autonomous AI agent proprietary, anonymized healthcare product, transaction, and chat commerce data sets using advanced large language models.

#Healthcare #AIinHealthcare #MedTech #StartupFunding #SoutheastAsia